![Stuart Travers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stuart Travers
Founder at Sentinel Oncology Ltd.
Stuart Travers active positions
Companies | Position | Start | End |
---|---|---|---|
Sentinel Oncology Ltd.
![]() Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 31/12/2004 | - |
Chief Operating Officer | 31/12/2004 | - | |
Founder | 31/12/2004 | - |
Career history of Stuart Travers
Former positions of Stuart Travers
Companies | Position | Start | End |
---|---|---|---|
Glaxo Wellcome, Inc. | Corporate Officer/Principal | - | - |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Cambridge Discovery Chemistry
![]() Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Corporate Officer/Principal | - | - |
Paradigm Therapeutics Ltd.
![]() Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - | - |
Statistics
International
United States | 4 |
United Kingdom | 3 |
Operational
Corporate Officer/Principal | 4 |
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 5 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Sentinel Oncology Ltd.
![]() Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Paradigm Therapeutics Ltd.
![]() Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Health Technology |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Cambridge Discovery Chemistry
![]() Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Commercial Services |
Glaxo Wellcome, Inc. | Health Technology |
- Stock Market
- Insiders
- Stuart Travers
- Experience